|
ZXDC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.765900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.593200E-01 |
| Normal-vs-Stage2 |
1.101850E-01 |
| Normal-vs-Stage3 |
7.473500E-02 |
| Normal-vs-Stage4 |
1.039590E-04 |
| Stage1-vs-Stage2 |
7.286300E-02 |
| Stage1-vs-Stage3 |
5.360000E-02 |
| Stage1-vs-Stage4 |
1.354480E-04 |
| Stage2-vs-Stage3 |
7.396400E-01 |
| Stage2-vs-Stage4 |
2.522600E-01 |
| Stage3-vs-Stage4 |
5.905700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.288300E-02 |
| Normal-vs-AfricanAmerican |
5.901600E-01 |
| Normal-vs-Asian |
3.236400E-01 |
| Caucasian-vs-AfricanAmerican |
5.078200E-01 |
| Caucasian-vs-Asian |
1.162980E-01 |
| AfricanAmerican-vs-Asian |
2.038000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.041900E-03 |
| Normal-vs-Female |
3.173600E-01 |
| Male-vs-Female |
2.40019999999674E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.735200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.423200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.981200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.856160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.872600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.664200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.390800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.357100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.464160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.626800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.64098999999585E-05 |
| Normal-vs-Grade 2 |
8.668400E-01 |
| Normal-vs-Grade 3 |
1.768350E-02 |
| Normal-vs-Grade 4 |
3.69590000000031E-05 |
| Grade 1-vs-Grade 2 |
3.559000E-03 |
| Grade 1-vs-Grade 3 |
2.17929999999367E-05 |
| Grade 1-vs-Grade 4 |
4.58789999990827E-07 |
| Grade 2-vs-Grade 3 |
9.655200E-03 |
| Grade 2-vs-Grade 4 |
2.42069999999428E-05 |
| Grade 3-vs-Grade 4 |
8.499300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.817530E-02 |
| Normal-vs-ccB subtype |
5.81450000000094E-05 |
| ccA subtype-vs-ccB subtype |
1.01480046588165E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.790600E-01 |
| Normal-vs-N1 |
7.641500E-02 |
| N0-vs-N1 |
4.226200E-01 |
|
|
